TP53 neoepitope is a high-affinity antigen peptide that targets HLA-A and is capable of activating CD8+ T cell-mediated cytotoxicity against TP53-mutant tumor cells. It holds promise for research involving solid tumors harboring TP53 hotspot mutations (such as R175H, R273H).